Home Pharmaceuticals and Healthcare Stomach Cancer and Gastric Cancer Treatment Market

Stomach Cancer and Gastric Cancer Treatment Market By Type (Programmed Cell Death Protein 1 (PD-1) Inhibitors, Human Epidermal Growth Factor Receptor (HER2) Antagonists, Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists, Others), By Application (Hospitals, Clinics), Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2025-2033

Report ID : MS15867
Author : Market Strides
Last Updated : Apr 24, 2025
Pages : 145
Starting From
USD 1850
Buy Now

Table Of Content

  1. Executive Summary
    1. Introduction
  2. Market Introduction
    1. Market Definition
    2. Scope of the Study
    3. Market Structure
  3. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  4. Market Factor Analysis
    1. Value Chain Analysis: Stomach Cancer And Gastric Cancer Treatment Market
    2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
  6. Recent Trends Analysis
  7. Impact of COVID-19 on Stomach Cancer And Gastric Cancer Treatment Market
    1. Pre and Post Covid -19 Market Scenario Analysis
    2. Market Recovery Timeline and Challenge
    3. Measures Taken by Top Players
  8. Regulatory Landscape
  9. Stomach Cancer And Gastric Cancer Treatment Market, By Type
    1. Introduction
      1. Market Size and Forecast, By Type
    2. Programmed Cell Death Protein 1 (PD-1) Inhibitors
      1. Market Size and Forecast, By Region
    3. Human Epidermal Growth Factor Receptor (HER2) Antagonists
      1. Market Size and Forecast, By Region
    4. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
      1. Market Size and Forecast, By Region
    5. Others
      1. Market Size and Forecast, By Region
  10. Stomach Cancer And Gastric Cancer Treatment Market, By Application
    1. Introduction
      1. Market Size and Forecast, By Application
    2. Hospitals
      1. Market Size and Forecast, By Region
    3. Clinics
      1. Market Size and Forecast, By Region
  11. Regional Overview
    1. Introduction
      1. Market Size and Forecast
    2. North America
      1. Market Size and Forecast
        1. By Type
          1. Programmed Cell Death Protein 1 (PD-1) Inhibitors
            1. Human Epidermal Growth Factor Receptor (HER2) Antagonists
              1. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
                1. Others
                2. By Application
                  1. Hospitals
                    1. Clinics
                  2. U.S.
                    1. By Type
                      1. Programmed Cell Death Protein 1 (PD-1) Inhibitors
                        1. Human Epidermal Growth Factor Receptor (HER2) Antagonists
                          1. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
                            1. Others
                            2. By Application
                              1. Hospitals
                                1. Clinics
                              2. Canada
                            3. Europe
                              1. Market Size and Forecast
                                1. By Type
                                  1. Programmed Cell Death Protein 1 (PD-1) Inhibitors
                                    1. Human Epidermal Growth Factor Receptor (HER2) Antagonists
                                      1. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
                                        1. Others
                                        2. By Application
                                          1. Hospitals
                                            1. Clinics
                                          2. U.K.
                                            1. By Type
                                              1. Programmed Cell Death Protein 1 (PD-1) Inhibitors
                                                1. Human Epidermal Growth Factor Receptor (HER2) Antagonists
                                                  1. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
                                                    1. Others
                                                    2. By Application
                                                      1. Hospitals
                                                        1. Clinics
                                                      2. Germany
                                                      3. France
                                                      4. Spain
                                                      5. Italy
                                                      6. Russia
                                                      7. Nordic
                                                      8. Benelux
                                                      9. Rest of Europe
                                                    3. APAC
                                                      1. Market Size and Forecast
                                                        1. By Type
                                                          1. Programmed Cell Death Protein 1 (PD-1) Inhibitors
                                                            1. Human Epidermal Growth Factor Receptor (HER2) Antagonists
                                                              1. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
                                                                1. Others
                                                                2. By Application
                                                                  1. Hospitals
                                                                    1. Clinics
                                                                  2. China
                                                                    1. By Type
                                                                      1. Programmed Cell Death Protein 1 (PD-1) Inhibitors
                                                                        1. Human Epidermal Growth Factor Receptor (HER2) Antagonists
                                                                          1. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
                                                                            1. Others
                                                                            2. By Application
                                                                              1. Hospitals
                                                                                1. Clinics
                                                                              2. Korea
                                                                              3. Japan
                                                                              4. India
                                                                              5. Australia
                                                                              6. Singapore
                                                                              7. Taiwan
                                                                              8. South East Asia
                                                                              9. Rest of Asia-Pacific
                                                                            3. Middle East and Africa
                                                                              1. Market Size and Forecast
                                                                                1. By Type
                                                                                  1. Programmed Cell Death Protein 1 (PD-1) Inhibitors
                                                                                    1. Human Epidermal Growth Factor Receptor (HER2) Antagonists
                                                                                      1. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
                                                                                        1. Others
                                                                                        2. By Application
                                                                                          1. Hospitals
                                                                                            1. Clinics
                                                                                          2. UAE
                                                                                            1. By Type
                                                                                              1. Programmed Cell Death Protein 1 (PD-1) Inhibitors
                                                                                                1. Human Epidermal Growth Factor Receptor (HER2) Antagonists
                                                                                                  1. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
                                                                                                    1. Others
                                                                                                    2. By Application
                                                                                                      1. Hospitals
                                                                                                        1. Clinics
                                                                                                      2. Turky
                                                                                                      3. Saudi Arabia
                                                                                                      4. South Africa
                                                                                                      5. Egypt
                                                                                                      6. Nigeria
                                                                                                      7. Rest of MEA
                                                                                                    3. LATAM
                                                                                                      1. Market Size and Forecast
                                                                                                        1. By Type
                                                                                                          1. Programmed Cell Death Protein 1 (PD-1) Inhibitors
                                                                                                            1. Human Epidermal Growth Factor Receptor (HER2) Antagonists
                                                                                                              1. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
                                                                                                                1. Others
                                                                                                                2. By Application
                                                                                                                  1. Hospitals
                                                                                                                    1. Clinics
                                                                                                                  2. Brazil
                                                                                                                    1. By Type
                                                                                                                      1. Programmed Cell Death Protein 1 (PD-1) Inhibitors
                                                                                                                        1. Human Epidermal Growth Factor Receptor (HER2) Antagonists
                                                                                                                          1. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
                                                                                                                            1. Others
                                                                                                                            2. By Application
                                                                                                                              1. Hospitals
                                                                                                                                1. Clinics
                                                                                                                              2. Mexico
                                                                                                                              3. Argentina
                                                                                                                              4. Chile
                                                                                                                              5. Colombia
                                                                                                                              6. Rest of LATAM
                                                                                                                          2. Competitive Landscape, 2024
                                                                                                                            1. Introduction
                                                                                                                            2. Stomach Cancer And Gastric Cancer Treatment Market Share Analysis, 2024 (%)
                                                                                                                              1. Market Share Analysis, 2024
                                                                                                                              2. Competition Ranking, 2024
                                                                                                                              3. Key Developments & Growth Strategies
                                                                                                                                1. Merger & Acquisition
                                                                                                                                2. Product Launch
                                                                                                                                3. Expansion
                                                                                                                              4. Consolidated SWOT Analysis of Key Players
                                                                                                                          3. Company Profile
                                                                                                                            1. Ipsen Pharma
                                                                                                                              1. Business Overview
                                                                                                                              2. Financial Data
                                                                                                                              3. Key Product Categories
                                                                                                                              4. Recent Developments
                                                                                                                            2. Celltrion Inc.
                                                                                                                            3. Eli Lilly
                                                                                                                            4. Merck & Co.
                                                                                                                            5. Inc.
                                                                                                                            6. Bayer AG
                                                                                                                            7. Bristol-Myers Squibb Company
                                                                                                                            8. Jiangsu Hengrui Medicine Co.
                                                                                                                            9. Ltd.
                                                                                                                            10. Novartis AG
                                                                                                                            11. Roche
                                                                                                                            12. TAIHO PHARMACEUTICAL CO.
                                                                                                                            13. LTD.

                                                                                                                          	

                                                                                                                          


                                                                                                                          A PHP Error was encountered
                                                                                                                          


                                                                                                                          Severity: Warning
                                                                                                                          

                                                                                                                          Message:  Undefined array key "list_tbl_fig"
                                                                                                                          

                                                                                                                          Filename: reports/toc.php
                                                                                                                          

                                                                                                                          Line Number: 79
                                                                                                                          


	
                                                                                                                          Backtrace:
                                                                                                                          
	
		
	
		
	
		
			
                                                                                                                          
			File: /var/www/html/application/views/frontend/reports/toc.php
                                                                                                                          
			Line: 79
                                                                                                                          
			Function: _error_handler			
                                                                                                                          

		
	
		
	
		
	
		
			
                                                                                                                          
			File: /var/www/html/application/controllers/Web.php
                                                                                                                          
			Line: 215
                                                                                                                          
			Function: view			
                                                                                                                          

		
	
		
	
		
			
                                                                                                                          
			File: /var/www/html/index.php
                                                                                                                          
			Line: 316
                                                                                                                          
			Function: require_once

                                                                                                                          Key Topics Covered
                                                                                                                          • Market Factors (Including Drivers and Restraint)
                                                                                                                          • Market Trends
                                                                                                                          • Market Estimates and Forcasts
                                                                                                                          • Competitive Analysis
                                                                                                                          • Future Market Opportunities
                                                                                                                          Secured & Verified Premium Quality SSL Certification

                                                                                                                          Payments Methods